Literature DB >> 9762166

[Liver resection in patients with polycystic liver disease].

C Vons1, D Chauveau, E Martinod, C Smadja, F Capron, J P Grunfeld, D Franco.   

Abstract

OBJECTIVES: Polycystic liver disease is sometimes responsible for chronic symptoms linked to hepatomegaly which can result in acute complications such hemorrhage or infection of cysts. The aim of this retrospective study was to evaluate the results of partial hepatic resection in patients with symptomatic or complicated polycystic liver disease.
METHODS: Twelve patients (11 women and one man, mean age 49) with diffuse polycystic liver disease were treated by partial liver resection (left lateral lobectomy in 7, left hepatectomy in 4, and extended right hepatectomy in 1). Four patients had terminal renal failures and three had chronic haemodialysis. Median follow-up was 34 months.
RESULTS: Ascites occurred postoperatively in 10 patients (83%) and was long-lasting (> 2 weeks) in 5; all patients with end-stage renal failure had long-lasting ascites. One of them died on the 40th postoperative day of ascites infection. Another patient with end-stage renal failure died two years postoperatively from chronic disabling ascites and malnutrition while awaiting kidney transplantation. The 10 other patients were markedly improved after partial liver resection, including a marked decrease in hepatomegaly, and the disappearance of chronic symptoms and cystic complications. This beneficial effect was incomplete in the two surviving patients with end-stage renal failure until kidney transplantation was performed.
CONCLUSION: These results suggest that partial liver resection is a highly effective treatment in patients with symptomatic polycystic liver disease, preferably before the onset of end-stage renal failure.

Entities:  

Mesh:

Year:  1998        PMID: 9762166

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  6 in total

1.  Combined hepatic resection with fenestration for highly symptomatic polycystic liver disease: A report on seven patients.

Authors:  Guang-Shun Yang; Qi-Gen Li; Jun-Hua Lu; Ning Yang; Hai-Bin Zhang; Xue-Ping Zhou
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

Review 2.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 3.  Surgical management of polycystic liver disease.

Authors:  Robert T Russell; C Wright Pinson
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

4.  Treatment of polycystic liver disease with resection-fenestration and a new classification.

Authors:  Tuan-Jie Li; Hai-Bin Zhang; Jun-Hua Lu; Jun Zhao; Ning Yang; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

5.  Severe polycystic liver diseases: hepatectomy or waiting for liver transplantation?: Two case reports.

Authors:  Zeyu Zhang; Kuan Hu; Jiajin Yang; Yufan Zhou; Zhiming Wang; Yun Huang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

6.  Liver Transplant for Unusually Large Polycystic Liver Disease: Challenges and Pitfalls.

Authors:  Pablo Serrano Rodriguez; Alfred Sidney Barritt; David Allen Gerber; Chirag Sureshchandra Desai
Journal:  Case Rep Transplant       Date:  2018-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.